Renal cell carcinomas (RCCs) comprise a heterogeneous group of tumors representing 2%-3% of all adult cancers. Among RCCs, the clear cell histotype (cRCC) is the most common, representing 80% of all primary renal neoplasias. cRCC can be familial or sporadic, with recurrent genomic deletions or translocations, suggesting that genetic mechanisms are involved in early tumorigenesis. In the context of an Italian research oncological project aimed to the identification of new molecular markers for cRCC at different tissues levels using an integrated molecular approach (DNA/RNA/protein), we performed a whole transcriptome/genome integrated analysis of primary cell cultures prepared from tumor, cortical and medullar surgical tissues using the Affy...
Renal cell carcinoma (RCC) incidence accounts for about 3 to 10 cases per 100,000 individuals with a...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Chromosomal loss of heterozigosity (LOH) is a common mechanism for the inactivation of tumor suppres...
The work described in this PhD thesis aimed to characterize 9 clear cell renal carcinoma primary cul...
Abstract: Background: Clear cell renal carcinoma (RCC) is the most common and invasive adult renal c...
Clear cell renal carcinomas (cRCC) is representing about 3% of all kidney cancers. No biomarkers for...
Background Renal cell carcinoma (RCC) is characterized by a number of diverse molecular aberrations...
Renal cell carcinoma (RCC) is the most widespread kidney tumor, which originates mostly from distal ...
Abstract Background Clear cell renal carcinoma (RCC) is the most common and invasive adult renal can...
The work comprised in this PhD thesis described the development of a novel mathematical and statisti...
Clear cell renal carcinoma (RCC) accounts for 80% of all primary kidney malignancies. It is characte...
Abstract Background Renal cell carcinoma (RCC) is characterized by a number of diverse molecular abe...
<div><p>Gene expression microarray and next generation sequencing efforts on conventional, clear cel...
We use Caki-1 cell line, derived from a human metastatic clear cell renal carcinoma (HTB-46, ATCC), ...
Renal cell carcinoma (RCC) incidence accounts for about 3 to 10 cases per 100,000 individuals with a...
Renal cell carcinoma (RCC) incidence accounts for about 3 to 10 cases per 100,000 individuals with a...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Chromosomal loss of heterozigosity (LOH) is a common mechanism for the inactivation of tumor suppres...
The work described in this PhD thesis aimed to characterize 9 clear cell renal carcinoma primary cul...
Abstract: Background: Clear cell renal carcinoma (RCC) is the most common and invasive adult renal c...
Clear cell renal carcinomas (cRCC) is representing about 3% of all kidney cancers. No biomarkers for...
Background Renal cell carcinoma (RCC) is characterized by a number of diverse molecular aberrations...
Renal cell carcinoma (RCC) is the most widespread kidney tumor, which originates mostly from distal ...
Abstract Background Clear cell renal carcinoma (RCC) is the most common and invasive adult renal can...
The work comprised in this PhD thesis described the development of a novel mathematical and statisti...
Clear cell renal carcinoma (RCC) accounts for 80% of all primary kidney malignancies. It is characte...
Abstract Background Renal cell carcinoma (RCC) is characterized by a number of diverse molecular abe...
<div><p>Gene expression microarray and next generation sequencing efforts on conventional, clear cel...
We use Caki-1 cell line, derived from a human metastatic clear cell renal carcinoma (HTB-46, ATCC), ...
Renal cell carcinoma (RCC) incidence accounts for about 3 to 10 cases per 100,000 individuals with a...
Renal cell carcinoma (RCC) incidence accounts for about 3 to 10 cases per 100,000 individuals with a...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Chromosomal loss of heterozigosity (LOH) is a common mechanism for the inactivation of tumor suppres...